MedPath

Role of Calcium Chloride Injection in Alleviating Atrial Fibrillation Post CABG

Phase 3
Recruiting
Conditions
Atrial Fibrillation
Interventions
Drug: Sodium Chloride 0.9% Inj
Registration Number
NCT06378021
Lead Sponsor
Helwan University
Brief Summary

This study hypothesize that injecting calcium chloride (CaCl2) into the major atrial ganglionated plexus (GPs) during on pump Coronary artery bypass graft (CABG) can reduce the incidence of Post operative Atrial fibrillation in the first 7 days after surgery.The study is designed to be prospective interventional study two armed RCT for on pump CABG patient.

The intervention arm will be injected with Calcium chloride in the four major atrial ganglionic plexus The control arm will be injected with sodium chloride to determine the effect of Calcium chloride on Post CABG Atrial fibrillation

Detailed Description

This study hypothesize that injecting calcium chloride into the major atrial ganglionic plexus (GPs) during On pump Coronary artery bypass graft (CABG) can reduce the incidence of Post operative Atrial fibrillation by calcium-induced autonomic neurotoxicity, the incidence of Post operative Atrial fibrillation can be reduced by suppressing the function of the major atrial GPs and the surrounding neural network that play an important role in initiating Post operative Atrial fibrillation. The study is designed to be prospective interventional study two armed RCT for on pump CABG patient. The plan of work will include dividing the patients into 2 randomized control groups In the intervention group patients will be injected with 5% Calcium chloride in the 4 Major atrial ganglionic plexus The other arm will be Coronary artery bypass graft patients who will be injected with sodium chloride 0.9% to compare the two groups to evaluate to evaluate the effect of Calcium chloride in post CABG atrial fibrillation between the 2 arms of the study.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  1. Patients more than 18 years old 2 ) patients undergoing On pump CABG
Exclusion Criteria
  1. patients >75 years of age

  2. Patients with Pre operative Atrial fibrillation

  3. Patients with Significant valvular disease

  4. Ejection fraction <30% 6. Combined surgery of any kind 7. Congenital heart disease 8. Abnormal severe liver or kidney dysfunction. 9. Patients undergoing Off-pump CABG 10. Poorly controlled hyperthyroidism 11. Refusal to enrollment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
patients who will receive their regular standard of care without calcium chloride injectionSodium Chloride 0.9% InjA group of patients who will undergo Coronary artery bypass graft surgery will be injected with normal saline in the ganglionic Plexus during Coronary artery bypass graft to act as a comparator to determine if calcium chloride injection alleviate Atrial fibrillation post surgery
Calcium chloride injection in ganglionated plexis for Atrial Fibrillation alleviation post CABGCalcium ChlorideThe Patients in the intervention arm will be injected with Calcium chloride in the 4 major atrial ganglionated plexis after the by pass is completed.
Primary Outcome Measures
NameTimeMethod
Change in number of patients who developed Atrial fibrillationUp to one week from the time of surgery determined by serial ECGs per day

Compare if calcium chloride injection decrease the percentage of patients who developed Atrial fibrillation in intervention group with those in placebo group

Secondary Outcome Measures
NameTimeMethod
Change in length of hospital stayUp to the time of patient discharge from the hospital (from the time of post Coronary artery bypass graft surgery)

investigate if calcium chloride will decrease duration of hospital stay compared with those in the placebo group who are injected with normal saline

Trial Locations

Locations (1)

Ain shams university

🇪🇬

Cairo, Abassia Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath